Maco, Mary Rose H.
HRN: 22-47-59 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/12/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/12/2023
01/18/2023
IVT
500mg
Q8
Acute Appendicitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes